Chang Hou

Chang Hou

Auto-generated profile, based on publicly available information

Chang Hou

Department of Cardiology

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
CHChang Hou
Chang Hou
MGMeng Guo
Meng Guo
YMYuliang Ma
Yuliang Ma
QLQi Li
Qi Li
CLChuanfen Liu
Chuanfen Liu
JLJian Liu
Jian Liu
Objectives. The present study is designed to investigate the impact of coronary angiography-derived index of microcirculatory resistance (caIMR) on left ventricular performance recovery. Background. IMR has been established as a gold standard for coronary microvascular assessment and a predictor of left ventricular recovery after ST-segment elevation myocardial infarction (STEMI). CaIMR is a novel and accurate alternative of IMR. Methods. The present study retrospectively included 80 patients with STEMI who underwent primary percutaneous coronary intervention (PCI). We offline performed the post-PCI caIMR analysis of the culprit vessel. Echocardiography was performed within the first 24 hours and at 3 months after the index procedure. Left ventricular recovery was defined as the change in left ventricular ejection fraction (LVEF) more than zero. Results. The mean age of the patients was 58.0 years with 80.0 male. The average post-PCI caIMR was 43.2. Overall left ventricular recovery was seen in 41 patients. Post-PCI caIMR (OR: 0.948, 95 CI: 0.9160.981, p=0.002), left anterior descending as the culprit vessel (OR: 3.605, 95 CI: 1.2310.567, p=0.019), and male (OR: 0.254, 95 CI: 0.0660.979, p=0.047) were independent predictors of left ventricular recovery at 3 months follow-up. A predictive model was established with the best cutoff value for the prediction of left ventricular recovery 2.33 (sensitivity 0.610, specificity 0.897, and area under the curve 0.765). In patients with a predictive model score less than 2.33, the LVEF increased significantly at 3 months. Conclusions. The post-PCI caIMR can accurately predict left ventricular functional recovery at 3 months follow-up in patients with STEMI treated by primary PCI, supporting its use in clinical practice.

9 March 2017 in Obesity Research & Clinical Practice
Verified
Journal Article
Closed access
PDF file
CHChang Hou
Chang Hou
BZBo Zheng
Bo Zheng
YYYing Yang
Ying Yang
XWXingang Wang
Xingang Wang
BZBin Zhang
Bin Zhang
BZBin Zhang
Bin Zhang

14 March 2022 in Chinese Journal of Hematology
Verified
Journal Article
Open access
CLC Q Lu
C Q Lu
CHC Hou
C Hou
PWP Wang
P Wang
LZL W Zhang
L W Zhang
YFY Fan
Y Fan
YXY Xu
Y Xu
探究不同时间进行修订版国际预后积分系统(IPSS-R)及WHO预后积分系统(WPSS)评分对异基因造血干细胞移植(allo-HSCT)治疗骨髓增生异常综合征(MDS)患者的预后评估价值。 回顾性分析2016年7月至2019年6月于苏州大学附属第一医院行allo-HSCT的184例MDS患者临床资料,在初诊及移植前两个时间点进行IPSS-R及WPSS评分,比较两者预后评估价值,分析影响移植预后的危险因素。 中位随访21.9(0.5~47.5)个月,移植后2年总体生存(OS)、无进展生存(PFS)率分别为(75.1±3.4)%、(71.6±3.6)%,2年复发(RR)率和无复发死亡率(NRM)分别为(11.9±0.1)%、(16.5±0.1)%。初诊时IPSS-R≤3.5分与>3.5分组OS、PFS差异无统计学意义(P=0.409;P=0.724),WPSS≤2分与>2分组OS、PFS差异无统计学意义(P=0.462;P=0.726)。移植前除外10例患者转化为急性髓系白血病(AML),174例患者可进行IPSS-R及WPSS评估,其中IPSS-R≤3.5分组OS、PFS率显著优于>3.5分组[OS:(88.6±4.1)%对(65.8±5.3)%,P=0.003;PFS:(87.6±4.2)%对(60.5±5.8)%,P=0.002],WPSS≤2分与>2分组间OS、PFS差异无统计学意义(P=0.584;P=0.565)。此外,移植前IPSS-R较初诊时相比改善组OS、PFS率显著优于未改善组[OS:(83.8±4.6)%对(69.3±5.8)%,P=0.027;PFS:(82.8±4.4)%对(64.0±7.2)%,P=0.006],多因素分析发现移植前TP53突变(P=0.047,HR=2.460,95% CI 1.014~5.971)和移植前IPSS-R>3.5分(P=0.021,HR=2.510,95% CI 1.151~5.476)是影响OS的独立不良预后因素,移植前细胞遗传学差及极差(P=0.008,HR=2.765,95% CI 1.305~5.856)和移植前IPSS-R>3.5分(P=0.017,HR=2.457,95% CI 1.175~5.141)是影响PFS的独立不良预后因素。 移植前进行IPSS-R评分对行allo-HSCT的MDS患者的预后评估有重要价值,移植前IPSS-R较初诊时改善的患者有着更好的预后。